400-81-075
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 5g | ￥ ƱȷɅƙƙ | 6 | > 10 | -- | 1 | -- | ￥ ƱȷɅƙƙ | - + | |
| 10g | ￥ ƱƋɅƙƙ | > 10 | 1 | 1 | -- | 1 | ￥ ƱƋɅƙƙ | - + | |
| 5g | ￥ ǕȦɅƙƙ | 1 | > 10 | 1 | 9 | 6 | ￥ ǕȦɅƙƙ | - + | |
| 100g | ￥ ƻǕƱɅƙƙ | -- | > 10 | -- | 5 | ￥ ƻǕƱɅƙƙ | - + | ||
| 500g | ￥ ƋȷȦɅƙƙ | -- | 4 | -- | -- | -- | -- | ￥ ƋȷȦɅƙƙ | - + |
| 1kg | ￥ ƻǕƙȌɅƙƙ | -- | -- | -- | -- | -- | ￥ ƻǕƙȌɅƙƙ | - + | |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
6.
[1]. Xiaoyu Cao, et al. Combination of PARP Inhibitor and Temozolomide to Suppress Chordoma Progression. J Mol Med (Berl). 019 Aug;97(8):118-119
[]. Adam L Hartman, et al. Potent anti-seizure effects of D-leucine. Neurobiol Dis. 015 Oct:8:46-5.
[]. Brian T Wilhelm, et al. Defining transcribed regions using RNA-seq. Nat Protoc. 010 Feb;5():55-66.
[4]. Yazmin Macotela, et al. Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One. 011;6(6):e1187.
H0-H15-H19-H5
P61-P64-P70-P71-P80-P0+P5-P04+P40-P05+P51+P8-P0-P6+P64-P40+P-P405-P501
109708 现货
￥ ǕȷɅƙƙ -5g
10798 现货
￥ ƱȷɅƙƙ -5g
1017417 现货
￥ ƱƋɅƙƙ -5g
101968 现货
￥ ƱſɅƙƙ -5g
10418 现货
￥ ƱƋɅƙƙ -5g
105160 现货
￥ ǕƱɅƙƙ -5g
100689 现货
￥ ƱȷɅƙƙ -5g
1051808 现货
￥ ƱɐɅƙƙ -5g
10669 现货
￥ ǕȌɅƙƙ -5g
910 货期咨询
沪ICP备17019645号
